Erythropoietic effects of vadadustat in patients with anemia associated with chronic kidney disease

MLA

Mark J. Koury, et al. Erythropoietic Effects of Vadadustat in Patients with Anemia Associated with Chronic Kidney Disease. Jan. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....95fbda48105c9cc626a3af0a7bab6c62&authtype=sso&custid=ns315887.

APA

Mark J. Koury, Rajiv Agarwal, Glenn M. Chertow, Kai‐Uwe Eckardt, Steven Fishbane, Tomas Ganz, Volker H. Haase, Mark R. Hanudel, Patrick S. Parfrey, Pablo E. Pergola, Prabir Roy‐Chaudhury, James A. Tumlin, Robert Anders, Youssef M. K. Farag, Wenli Luo, Todd Minga, Christine Solinsky, Dennis L. Vargo, & Wolfgang C. Winkelmayer. (2022). Erythropoietic effects of vadadustat in patients with anemia associated with chronic kidney disease.

Chicago

Mark J. Koury, Rajiv Agarwal, Glenn M. Chertow, Kai‐Uwe Eckardt, Steven Fishbane, Tomas Ganz, Volker H. Haase, et al. 2022. “Erythropoietic Effects of Vadadustat in Patients with Anemia Associated with Chronic Kidney Disease,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....95fbda48105c9cc626a3af0a7bab6c62&authtype=sso&custid=ns315887.